The INC has the pleasure of submitting its feedback prepared in consultation with the interinstitutional WG on oncopediatrics of the 2nd National Cancer Plan of Luxembourg. -Science-based paediatric drug development: We value the introduction of paediatric medicine development based on the molecular target. This acknowledges that children deserve access to treatments designed with their specific needs in mind.
IND
Institut National du Cancer (INC) - Luxembourg
Other · Luxembourg · EU Transparency Register 627490337969-58
1
position filed
in the 583 files tracked
1
legislative file
of 583 tracked
0
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 159 other organisations on this site, they rank #140 by legislative files engaged — a count of participation, not a measure of influence.
3.8
declared lobbying FTE
self-declared
—
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2020
in the register since
Declares membership of
- Organisation of European Cancer Institutes (OECI): https://www.oeci.eu
- European Cancer Organisation (ECO): https://www.europeancancer.org
Self-declared to the EU Transparency Register (snapshot 2 Sept 2026).
- Register category
- Other organisations
- Registered as
- Institut National du Cancer (INC)
- Head office
- Strassen, Luxembourg
Self-declared to the EU Transparency Register (snapshot 2 Sept 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track Institut in PolicySpeak: request access →
Work at Institut National du Cancer (INC) - Luxembourg? so we know who speaks for it.
Their record over time
Institut National du Cancer (INC) - Luxembourg filed 1 position on 6 Nov 2023, across 1 of the 583 legislative files tracked here.
What they argued
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Institut National du Cancer (INC) - Luxembourg next to another organization. Same files, same register facts, side by side. Compare →
Is this your organization?
Everything on this page comes from Institut National du Cancer (INC) - Luxembourg’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.